Xenobiotica 1985-10-01

Can a 1,2-oxygen shift of a nicotinamide N-oxide derivative occur in vivo?

P Dostert, M Strolin Benedetti, V Rovei, R L Smith

Index: Xenobiotica 15(10) , 799-803, (1985)

Full Text: HTML

Abstract

Using the N-oxide derivative of niaprazine, a nicotinamide-based drug, as substrate, the possibility of a 1,2-oxygen shift from N to adjacent C occurring in vivo has been investigated. By comparison of the percentage of the 6-pyridone derivative formed after administration of 14C-niaprazine to rats with that obtained after giving 14C-niaprazine N-oxide, it has been shown that a 1,2-oxygen shift might contribute to the formation of 6-pyridone derivatives as metabolites of nicotinamide-related drugs in vivo.

Related Compounds

  • Nicotinamide N-ox...

Related Articles:

Effects of excess nicotinamide administration on the urinary excretion of nicotinamide N-oxide and nicotinuric acid by rats.

2004-01-01

[Biosci. Biotechnol. Biochem. 68(1) , 44-50, (2004)]

Pharmacokinetics and biochemistry studies on nicotinamide in the mouse.

1994-01-01

[Cancer Chemother. Pharmacol. 34(5) , 399-404, (1994)]

Plasma and urine pharmacokinetics of niacin and its metabolites from an extended-release niacin formulation.

2007-08-01

[Int. J. Clin. Pharmacol. Ther. 45(8) , 448-54, (2007)]

Niacin catabolism in rodents.

1990-04-01

[J. Nutr. Sci. Vitaminol. 36(2) , 87-98, (1990)]

NAD (P) H-dependent reduction of nicotinamide N-oxide by an unique enzyme system consisting of liver microsomal NADPH-cytochrome C reductase and cytosolic aldehyde oxidase.

1984-12-28

[Biochem. Biophys. Res. Commun. 125(3) , 1117-22, (1984)]

More Articles...